|
Status |
Public on Jan 01, 2023 |
Title |
Tamoxifen-induced Ghr deletion in SV40 C3(1) T-antigen mouse prostates |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Seven-month old tamoxifen-inducible Ghr recombination mice in T-antigen mouse model of prostate cancer (Ghrflox/flox;ROSA26Cre-ERT2+/0;SV40 C3(1) T-antigen+/0) or tamoxifen-control mice (Ghrflox/flox;SV40 C3(1) T-antigen+/0) were treated with 250 mg/kg tamoxifen for five straight days. The dorsolateral prostate of each mouse was collected one month after final treatment and RNA was collected. Samples include
|
|
|
Overall design |
5 samples. Two biological replicates of tamoxifen-control DLPs and three biological replicates of Ghr deletion DLPs.
|
|
|
Contributor(s) |
Unterberger C, Marker P, McIlwain S, Tsourkas P |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Mar 01, 2022 |
Last update date |
Jan 03, 2023 |
Contact name |
Paul Marker |
E-mail(s) |
paul.marker@wisc.edu
|
Phone |
608-890-2150
|
Organization name |
University of Wisconsin Madison
|
Street address |
600 Highland Avenue
|
City |
Madison |
State/province |
WI |
ZIP/Postal code |
53792 |
Country |
USA |
|
|
Platforms (1) |
GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
Samples (5)
|
GSM5928110 |
Mouse dorsolateral prostate Tamoxifen-control replicate 1 |
GSM5928111 |
Mouse dorsolateral prostate Tamoxifen-control replicate 2 |
GSM5928112 |
Mouse dorsolateral prostate Ghr deletion replicate 1 |
GSM5928113 |
Mouse dorsolateral prostate Ghr deletion replicate 2 |
GSM5928114 |
Mouse dorsolateral prostate Ghr deletion replicate 3 |
|
Relations |
BioProject |
PRJNA811573 |